Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $76.9600 (-0.61%) ($76.9600 - $77.3500) on Wed. Jun. 21, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.51% (three month average) | RSI | 68 | Latest Price | $76.9600(-0.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.8% a day on average for past five trading days. | Weekly Trend | LGND advances 4.3% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(46%) XBI(44%) VFMO(39%) XAR(39%) PAVE(38%) | Factors Impacting LGND price | LGND will decline at least -1.255% in a week (0% probabilities). UUP(-27%) VXX(-18%) TBT(-18%) EDOC(-9%) VIXM(-6%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.255% (StdDev 2.51%) | Hourly BBV | -0.2 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $77.63(-0.86%) | 10 Day Moving Average | $75.82(1.5%) | 20 Day Moving Average | $74.4(3.44%) | To recent high | -3.4% | To recent low | 13.8% | Market Cap | $1.237b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |